Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1825 of 5804
-
New mesh tube aims to prevent dialysis vein blockages
Disease control Recruiting nowThe goal of this observational study is to investigate the safety and efficacy of the WRAPSODY CIE in a real-world North American population. Participants treated with the WRAPSODY CIE device in accordance with the device instructions for use will be followed in accordance with s…
Sponsor: Merit Medical Systems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New test may spot hidden cancer cells in endometrial patients
Diagnosis Recruiting nowPatients enrolled in the study will be randomized before surgery: in one study arm, the search for lymph node metastases in surgically removed sentinel lymph nodes will occur using the ultrastaging method (standard), while in the other arm it will be conducted using the OSNA meth…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New hope for recurrent brain cancer? early trial of CUE-102 begins
Disease control Recruiting nowThe goal of this study is to evaluate the safety of the experimental drug, CUE-102, and establish the recommended dose of CUE-102 for participants with Recurrent Glioblastoma (GBM). The name of the study drug involved in this study is: -CUE-102 (a type of fusion protein)
Phase: PHASE1 • Sponsor: David Reardon, MD • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Experimental antibody takes on brain cancer in tiny trial
Disease control TerminatedThis phase Ib trial tests the safety and side effects of glofitamab after pre-treatment with obinutuzumab and how well they work in treating patients with central nervous system (CNS) lymphoma. Glofitamab is a bispecific antibody that can bind to two different antigens (substance…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Pocket-Sized heart test could catch hidden AFib before it strikes
Diagnosis ENROLLING_BY_INVITATIONThe goal of this prospective, non-randomized pilot study is to learn whether predictions from a previously validated 12-lead ECG-based artificial intelligence (AI) algorithm (ECG-AI) identify people more likely to have undiagnosed atrial fibrillation (AF). The main questions it …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Real-World data sought on new prostate cancer drug
Knowledge-focused Recruiting nowThis is a local prospective, multicenter, long-term, non-interventional study using primary data collection to describe the routine clinical practice of patients with mCRPC treated with lutetium (177Lu) vipivotide tetraxetan. The observation period will be from date of start of t…
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Could inducing labor at 39 weeks cut C-Sections? new chinese trial aims to find out
Knowledge-focused Recruiting nowThe investigators are committed to identifying the optimal timing of delivery for low-risk pregnancies. While current guidelines typically recommend induction at 41 weeks, emerging evidence suggests that elective induction at 39 weeks may lead to improved maternal and neonatal ou…
Phase: NA • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Money talks, parenting walks: couples program aims to reduce harsh discipline
Knowledge-focused OngoingMany families in India experience intimate partner violence (IPV) and financial stress, both of which can harm the way parents interact with and discipline their children. When parents are under stress, they may be more likely to use harsh physical discipline or be less involved …
Phase: NA • Sponsor: Shruti Shukla • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can Biomarker-Guided biologics tame psoriasis and arthritis?
Disease control Recruiting nowThe inclusion criteria for this study were patients aged 18 to 75 years with a confirmed diagnosis of psoriasis by a dermatologist or psoriatic arthritis by a rheumatologist. Patients with active infections or suspected malignancies were excluded. A total of 40 patients with pso…
Phase: PHASE4 • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:34 UTC
-
New pill KDS2010 aims to shed pounds in obesity trial
Disease control Recruiting nowThis is a randomized, double-blind, placebo-controlled, dose-finding, Phase 2a study designed to evaluate the safety and efficacy of KDS2010 in overweight or obese patients. Based on preliminary efficacy observed in the Phase 1 study, this clinical trial is being conducted in Kor…
Phase: PHASE2 • Sponsor: NeuroBiogen Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New antibody drug takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThe purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, this study will evaluate how much LY4175408 gets into the bloodstream, how it is broken down, and how long it takes the body to get rid of it. …
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a gorilla virus help beat HIV? new vaccine trial launches
⭐️ VACCINE ⭐️ Recruiting nowA Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine (GRAdHIVNE1 Vaccine), Administered to Healthy Adults Living without HIV and Living with HIV, in Southern Africa
Phase: PHASE1 • Sponsor: International AIDS Vaccine Initiative • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:04 UTC
-
Could a ketone drink boost exercise in heart failure patients?
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical research study is to test what effects a ketone drink will have in people with heart failure with preserved ejection fraction (HFpEF), including on exercise and heart function. Patients with HFpEF often have difficulty exercising, and our goal is to unde…
Phase: PHASE2 • Sponsor: Duke University • Aim: Symptom relief
Last updated Jun 26, 2026 18:14 UTC
-
New vacuum tool could revolutionize kidney stone surgery
Disease control ENROLLING_BY_INVITATIONThe removal rate, complication risk and operation time of ureteral soft scope combined with negative pressure suction sheath therapy for patients with high-load kidney stones (2-3cm) are still controversial. Therefore, the safety and effectiveness of flexible ureteroscope combine…
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:15 UTC
-
New obesity drug XW003 takes on semaglutide in Head-to-Head trial
Disease control OngoingThe aim of the study is to compare the efficacy and safety of XW003 injection versus semaglutide injection in Chinese adults with obesity
Phase: PHASE2 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Glasses that help you hear: new study tests smart spectacles for hearing loss
Symptom relief Recruiting nowFollowing informed consent signature and upon verification of eligibility and execution of informed consent, subjects will be assigned a study code. The study comprises two groups. Screening visit will be conducted for both groups and include hearing test battery to assess hearin…
Phase: PHASE2, PHASE3 • Sponsor: Nuance Hearing • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New study tests which shoulder pain treatment lasts longer
Symptom relief CompletedThis study aims to compare the clinical effectiveness of two interventional treatments for chronic shoulder pain related to suprascapular nerve pathology: ultrasound-guided suprascapular nerve block and suprascapular nerve radiofrequency ablation (RFA). A total of 104 patients w…
Phase: NA • Sponsor: Nida Koçer Nazlıgül • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
One-Hour sperm wait could boost IVF success, new study suggests
Knowledge-focused OngoingThis research is being done to determine if producing sperm after an ultrashort period of abstinence (1 hour of abstinence) will be effective in improving the rates of embryos with normal chromosomes (structures that carry genetic information) during in vitro fertilization (IVF) …
Phase: NA • Sponsor: UConn Health • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Spinal surgery breakthrough? simple injection may cut pain and blood loss
Symptom relief CompletedThis study aims to evaluate the effects of ultrasound-guided bilateral erector spinae plane block on intraoperative pain control and bleeding in patients undergoing major spinal surgery. Participants will be randomly assigned to two groups: one group will receive the Erector Spin…
Phase: NA • Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
New drug MRG007 enters early human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis is an open-label, multi-center, phase I study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of MRG007 (ARR-217) in patients with unresectable locally advanced or metastatic solid tumors.
Phase: PHASE1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC